Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems
Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems
Sayona Mining (ASX:SYA) announced that their preliminary technical study at their NAL lithium carbonate plant study produces an NPV of A$3.2bn. Sayona's Managing Director, Brett Lynch commented: "Significantly, NAL is set to become the only lithium operation with a concentrator and carbonate plant all on the same site in North America. Shares are trading flat at 18 cents.
Sayona礦業(澳大利亞證券交易所股票代碼：SYA)宣佈，他們在NAL碳酸鋰工廠研究的初步技術研究產生了32億澳元的淨現值。董事的總經理佈雷特·林奇評論說：“值得注意的是，NAL將成為北美唯一一家同時擁有濃縮廠和碳酸鹽工廠的鋰企業。目前股價持平於18美分。”
Tamboran Resources (ASX:TBN) has entered into a Framework Agreement with the Clean Energy Fuels Australia (CEFA) to obtain exclusivity over gas compression and liquefaction facilities from the Beetaloo Basin. MD and CEO, Joel Riddle, said: "This is the first step in fulfilling our promise to provide these remote communities with alternative affordable and cleaner fuel." Shares are trading flat at 21 cents.
坦博蘭資源公司(澳大利亞證券交易所股票代碼：TBN)已與澳大利亞清潔能源燃料公司(CEFA)達成框架協定，獲得Beetaloo盆地天然氣壓縮和液化設施的獨家經營權。MD兼首席執行官喬爾·裡德爾說：“這是實現我們的承諾的第一步，我們承諾為這些偏遠社區提供負擔得起的替代燃料和更清潔的燃料。”股票交易持平於21美分。
Imagion Biosystems (ASX:IBX) is set to complete the MagSense HER2 Phase 1 Study. Bob Proulx, Imagion's CEO, commented, "this now provides strong footing for us to move ahead with our HER2 breast cancer program." Shares are trading 29.17 per cent higher at 1.55 cents.
Imagion生物系統公司(澳大利亞證券交易所市場代碼：IBX)將完成MagSense HER2第一階段研究。Imagion公司首席執行官鮑勃·普羅克斯評論說：“這為我們推進HER2乳腺癌專案奠定了堅實的基礎。”該公司股價上漲29.17%，至1.55美分。
譯文內容由第三人軟體翻譯。